The New York Times
June 19, 2015
I HAVE a very rare and aggressive type of skin cancer — Merkel cell carcinoma — for which there is no approved cure, and I’m participating in a clinical trial to deal with it. If successful, the trial will show that the drug I’m being given at least manages what is now an often fatal disease.
Unfortunately, participation in clinical trials by cancer patients is, like my disease, extremely rare. Only roughly 3 percent of all cancer patients in the United States ever agree to join a trial. Among women and many minorities, the participation rates are even lower.
The authoritative source on Merkel cell carcinoma.
December 27, 2019